Science and Medicine: Infectious Diseases

Dr. Ekaterina Dadachova

Dr. Dadachova is currently the Sylvia and Robert Olnick Faculty Scholar in Cancer Research and an associate professor of nuclear medicine and microbiology and immunology at the Albert Einstein College of Medicine of Yeshiva University. She received her Bachelor of Chemistry degree in 1986 from Moscow State University, Moscow, Russia. After obtaining her PhD in physical chemistry in 1992 from the same institution she emigrated to Australia where in 1993 she started postdoctoral work at the biomedicine and health program, Australian Nuclear Science and Technology Organization (ANSTO). Dr. Dadachova was given a task to develop a separation procedure for production of radioactive isotopes for medical applications. In 1995 she was invited as a guest scholar to Oak Ridge National Laboratory (ORNL), TN where she worked for 6 months at the production of isotopes in nuclear reactor and at making radioactive antibodies for cancer treatment. On return to ANSTO from ORNL she was promoted to research scientist position. In 1998 Dr. Dadachova was invited by Dr. Martin Brechbiel, of the National Cancer Institute, NIH to join his radioimmune and inorganic chemistry section as a visiting associate. During her 2 years at NIH she participated in all aspects of pre-clinical development and evaluation of radioactive drugs from chemistry to experimental therapy and toxicity studies. In 2000 Dr. Dadachova was recruited by the department of nuclear medicine, AECOM as assistant professor of nuclear medicine and director of radiochemistry. She has developed an active research program in novel therapies of cancer and infectious diseases using radioactive drugs. To date, Dr. Dadachova has published 91 peer-reviewed papers and is named inventor on 12 patents. Ongoing research projects in her laboratory are funded by NIH, research foundations and industry grants. She currently serves on the editorial boards of “Nuclear Medicine and Biology” and “Cancer Biotherapy and Radiopharmaceuticals” journals. Sample Titles Melanin Pigment as an Energy Transducer in Microorganisms and its Potential Applications in Bioremediation New Approaches to the Therapy of Infectious Disease Bismuth-213 in Radioimmunotherapy...

view

Dr. Meredith Hawkins

Dr. Meredith Hawkins is associate professor of medicine in the diabetes research and training center at the Albert Einstein College of Medicine of Yeshiva University. Her current research interests include the regulation of hepatic glucose production by hyperglycemia per se in type 2 diabetes mellitus, and the effects of nutrient excess on metabolic features of the insulin resistance syndrome. Dr. Hawkins has a tremendous interest to restrain the burgeoning epidemic of obesity and diabetes in the developing world. During the last ten years she has worked with key institutions in Uganda, Rwanda and India, to collaborate toward this vision. Dr. Hawkins earned her M.D. degree cum laude from the University of Toronto and a Master of Science in clinical research methods cum laude from the Albert Einstein College of Medicine. She is associate editor of the “American Journal of Physiology,” and secretary treasurer of the American Federation of Medical Research. Dr. Hawkins’ current research interests include the effects of nutrient excess on insulin resistance, nutritional regulation of adipose tissue macrophages, and the regulation of hepatic glucose production by hyperglycemia per se in diabetes mellitus. Dr. Hawkins is a Beeson Scholar of the American Federation of Aging Research, and has received research grants from the National Institutes of Health, the American Diabetes Association, the Juvenile Diabetes Foundation International and the Diabetes Action Foundation International. She is the recipient of numerous honors and awards, including the Outstanding Clinical Associate Physician Award from the National Institutes of Health and the Junior Physician Scientist Award from the American Federation of Medical Research. She was recently awarded the Novartis Young Investigator award in Diabetes Research, an international prize given to the most outstanding clinical investigator under the age of 45 who is conducting diabetes or obesity research. Sample Titles Global Diabetes: Tackling the Twenty-First Century...

view
Page 1 of 11